Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Filtered Gene green Rank description Interaction Map Network Comparison Type network_comparison red
Results: HTML CSV LaTeX Showing element 51 to 100 of 77072 in total 
Value Type: Measured
Filtered: 0

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
red\vspace{3pt}}\\
\hline
\hline
\multirow{10}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
500\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rwd domain containing 1; ptd013 protein; cgi-24 protein. [source:refseq;acc:nm\_015952]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
501\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
h2a histone family, member j isoform 1. [source:refseq;acc:nm\_018267]\vspace{3pt}}&&&&\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
502\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
brca1 associated protein. [source:refseq;acc:nm\_006768]\vspace{3pt}}&&&&\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
837\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-glutamyltranspeptidase 2 (ec 2.3.2.2) (gamma-glutamyltransferase 2) (fragment). [source:swissprot;acc:p36268]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&&\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
838\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-glutamyltransferase-like activity 4; gamma-glutamyltranspeptidase-like. [source:refseq;acc:nm\_080920]\vspace{3pt}}&&&&\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
839\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cobw-like protein. [source:refseq;acc:nm\_018491]\vspace{3pt}}&&&&\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
840\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
translin-associated protein x (translin-associated factor x). [source:swissprot;acc:q99598]\vspace{3pt}}&&&&\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
841\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-glutamyltransferase. [source:sptrembl;acc:q14390]\vspace{3pt}}&&&&\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
842\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-glutamyltranspeptidase 1 precursor (ec 2.3.2.2) (gamma- glutamyltransferase 1) (cd224 antigen). [source:swissprot;acc:p19440]\vspace{3pt}}&&&&\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
843\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-glutamyltranspeptidase 5 precursor (ec 2.3.2.2) (gamma- glutamyltransferase 5) (ggt-rel). [source:swissprot;acc:p36269]\vspace{3pt}}&&&&\\\cline{1-3}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
5.56738\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
10\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
serpin b12. [source:swissprot;acc:q96p63]\vspace{3pt}}}&&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
35.8425\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
199.549\vspace{3pt}}}\\\cline{2-2}\cline{4-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
11\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&&\\\cline{2-2}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
168\vspace{3pt}}&&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
193.982\vspace{3pt}}}&\\\cline{2-2}\cline{4-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
280\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&&\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
5.71669\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
11\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
hurpin (hacat uv-repressible serpin) (protease inhibitor 13) (headpin) (serpin b13). [source:swissprot;acc:q9uiv8]\vspace{3pt}}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
34.8539\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
199.249\vspace{3pt}}}\\\cline{2-2}\cline{4-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
12\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&&\\\cline{2-2}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
169\vspace{3pt}}&&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
193.532\vspace{3pt}}}&\\\cline{2-2}\cline{4-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
281\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&&\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
6.50325\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
14\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
cyclin h (mo15-associated protein) (p37) (p34). [source:swissprot;acc:p51946]\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
20.0687\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
130.512\vspace{3pt}}}\\\cline{2-2}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
258\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
124.009\vspace{3pt}}&\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
10.6048\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
9\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitously transcribed y chromosome tetratricopeptide repeat protein (ubiquitously transcribed tpr protein on the y chromosome). [source:swissprot;acc:o14607]\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
36.1876\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
383.762\vspace{3pt}}}\\\cline{2-2}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
166\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
373.157\vspace{3pt}}&\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
11.5\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
176\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
protocadherin 16 precursor (cadherin 19) (cadherin fibroblast 1). [source:swissprot;acc:q96jq0]\vspace{3pt}}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.21739\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
14\vspace{3pt}}}\\\cline{2-2}\cline{4-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
190\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&&\\\cline{2-2}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
489\vspace{3pt}}&&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
2.5\vspace{3pt}}}&\\\cline{2-2}\cline{4-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
819\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&&\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
14.3333\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
121\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4-aminobutyrate aminotransferase, mitochondrial precursor (ec 2.6.1.19) (gamma-amino-n-butyrate transaminase) (gaba transaminase) (gaba aminotransferase) (gaba-at) (gaba-t). [source:swissprot;acc:p80404]\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3721\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
19.6667\vspace{3pt}}}\\\cline{2-2}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
460\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.3334\vspace{3pt}}&\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
15\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
16\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
protein transport protein sec24c (sec24-related protein c). [source:swissprot;acc:p53992]\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{2-2}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
443\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14\vspace{3pt}}&\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
17.5166\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
jumonji protein. [source:swissprot;acc:q92833]\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1751660\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}\\\cline{2-2}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
755\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
17.5166\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
17.6611\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
21\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
syntaxin 10 (syn10). [source:swissprot;acc:o60499]\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.73106\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
118.878\vspace{3pt}}}\\\cline{2-2}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
269\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
101.217\vspace{3pt}}&\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
64\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
phosphatidylinositol-4-phosphate 3-kinase c2 domain-containing beta polypeptide (ec 2.7.1.154) (phosphoinositide 3-kinase-c2-beta) (ptdins-3-kinase c2 beta) (pi3k-c2beta) (c2-pi3k). [source:swissprot;acc:o00750]\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1800000\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}\\\cline{2-2}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
428\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0\vspace{3pt}}\\\hline
\multirow{6}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
camp-regulated phosphoprotein 19 (arpp-19) [contains: camp-regulated phosphoprotein 16 (arpp-16)]. [source:swissprot;acc:p56211]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.21053\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
99\vspace{3pt}}\\\cline{2-3}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
184\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 7 (adp-ribosylation factor-like protein lak). [source:swissprot;acc:p56559]\vspace{3pt}}}&&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.21053\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
23\vspace{3pt}}}\\\cline{2-2}\cline{4-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
195\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&&\\\cline{2-2}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
464\vspace{3pt}}&&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
4\vspace{3pt}}&\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
483\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
camp-regulated phosphoprotein 19 (arpp-19) [contains: camp-regulated phosphoprotein 16 (arpp-16)]. [source:swissprot;acc:p56211]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
80\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
99\vspace{3pt}}\\\cline{2-3}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
807\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 7 (adp-ribosylation factor-like protein lak). [source:swissprot;acc:p56559]\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
23\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
21\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
50\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor 4 (immunoglobulin transcription factor 2) (itf-2) (sl3-3 enhancer factor 2) (sef-2). [source:swissprot;acc:p15884]\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.09524\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
44\vspace{3pt}}}\\\cline{2-2}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
407\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
23\vspace{3pt}}&\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
23.6984\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
64\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
dna helicase homolog (fragment). [source:sptrembl;acc:q9y645]\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.03615\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
48.2534\vspace{3pt}}}\\\cline{2-2}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
713\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
24.555\vspace{3pt}}&\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
11.6763\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
305.45\vspace{3pt}}}\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&&&&\\\cline{2-3}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
114\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
279.29\vspace{3pt}}}&\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
115\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/